Corrigendum: Usefulness and Potential Pitfalls of Long-Acting Growth Hormone Analogues (Front. Endocrinol., (2021), 12, (637209), 10.3389/fendo.2021.637209)

ERROR IN TABLE 1, 5^TH COLUMN, 19^TH ROW In the original article, there was a mistake in Table 1 as published. In Table 1, 5th column, 19th row, the company “Alteogen” under the “Current Status” column was incorrectly stated that the company was “bankrupt in 2009”. This statement is incorrect as the company remains a currently viable bio-tech company globally. The authors apologize for this inadvertent error with the statement and a modified Table 1 is provided below, where the statement “bankrupt in 2009” is now deleted. This new table does not change the scientific conclusions of the article in any way. The original article has been updated.